Trial · NCT04243629
Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes
NCT04243629, Not applicable, Unknown, McGill University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes. Trials, record NCT04243629. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04243629
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes
- NCT number
- NCT04243629
- Status
- Unknown
- Phases
- Not applicable
- Enrollment
- 26 participants, estimated
- Lead sponsor
- McGill University
- Conditions
- Diabetes Mellitus, Type 1, Type 1 Diabetes, Postprandial Hyperglycemia
- Interventions
- Rapid-Acting Insulin, Placebo, Pramlintide Acetate, Artificial Pancreas
- First posted
- 2020-01-28
- Last updated
- 2023-03-15
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Time in target range | 4 weeks | Time each participant spent with glucose level in target range (3.9 - 10.0 mmol/L) |
| Secondary | Time between 3.9 - 7.8 mmol/L | 4 weeks | Percentage of time each participant spent with glucose levels between 3.9 - 7.8 mmol/L |
| Secondary | Time below 3,9, 3.3, and 2.8 mmol/L | 4 weeks | Percentage of time each participant spent with glucose levels below 3.9, 3.3, and 2.8 mmol/L |
| Secondary | Time above 7.8, 10.0, 13.9, 16.7 mmol/L | 4 weeks | Percentage of time each participant spent with glucose levels above 7.8, 10.0, 13.9, and 16.7 mmol/L |
| Secondary | Mean glucose level | 4 weeks | Each participant's mean glucose level |
| Secondary | Total insulin delivery | 4 weeks | Each participant's total insulin delivery |
| Secondary | Standard deviation and coefficient of variance | 4 weeks | Each participant's standard deviation and coefficient of variance of glucose levels as a measure of glucose variability |
| Secondary | Gastrointestinal symptoms | 4 weeks | Number of each participant's gastrointestinal symptoms |
| Secondary | Number of hypoglycemia events | 4 weeks | Each participant's number of hypoglycemia events defined as at least 15 min below 3.0 mmol/L with the end of the event being 15 minutes \> 3.9 mmol/L. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04243629
GET https://conductscience.org/api/trials/v1/NCT04243629/registered